中文名 | GSK-J4 |
英文名 | GSK-J4 |
别名 | 6-三碘苯酚 1373423-53-0 的盐酸盐 GSK J4 游离(检测J4溶样不要用甲醇,会发生酯交换) H3K27ME3DEMETHYLASE抑制剂(GSK-J4) N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯 |
英文别名 | GSK-J4 GSK J4 GSK J4 HCl ethyl 3-[[2-pyridin-2-yl-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino]propanoate Ethyl 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoate N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-beta-alanine ethyl ester |
CAS | 1373423-53-0 |
化学式 | C24H27N5O2 |
分子量 | 417.5 |
InChIKey | WBKCKEHGXNWYMO-UHFFFAOYSA-N |
密度 | 1.216±0.06 g/cm3(Predicted) |
沸点 | 581.2±50.0 °C(Predicted) |
溶解度 | DMSO: 可溶20mg/mL,澄清 |
酸度系数 | 5.95±0.10(Predicted) |
存储条件 | 2-8°C |
稳定性 | 从提供的购买之日起稳定1年。在DMSO或乙醇中的溶液可以在-20 ° 储存长达3个月。 |
外观 | 棕褐色半固体 |
颜色 | white to beige |
体外研究 | GSK-J4 has cellular activity in Flag-JMJD3-transfected HeLa cells, in which GSK-J4 prevents the JMJD3-induced loss of nuclear H3K27me3 immunostaining. Administration of GSK-J4 increases total nuclear H3K27me3 levels in untransfected cells. GSK-J4 significantly reduces the expression of 16 of 34 LPS-driven cytokines, including tumour-necrosis factor-α (TNF-α). GSK-J4 (5 μM; 48 hours) causes a more than 3-fold increase in mouse podocyte H3K27me3 content. H3K27me3 levels in cultured podocytes, GSK-J4 reduces Jagged-1 mRNA and Jagged-1 protein levels. Correspondingly, when exposed podocytes to the inducer of dedifferentiation TGF-β1, pretreatment with GSK-J4 preventes both the increase in intracellular N1-ICD levels and the increase in α-SMA and the decrease in podocin mRNA levels. GSK-J4 (10, 25 nM) acts upon DCs promoting the differentiation of Treg cells, improving Treg stability and suppressive capacities, without affecting the differentiation of Th1 and Th17 cells. GSK-J4 inhibits JMJD3 expression that is induced by TGF-β1. GSK-J4 inhibits H3K4 demethylation at Xist , Nodal , and HoxC13 in female embryonic stem cells. |
体内研究 | GSK-J4 Hydrochloride (10 mg/kg; i.p.; thrice-weekly for 10 weeks) attenuates the development of kidney disease in diabetic mice. GSK-J4 (0.5 mg/kg, i.p.) significantly reduces the severity and delays the onset of the disease of the mouse model of experimental autoimmune encephalomyelitis. Animal Model: Eight-week-old male db/m and db/db mice Dosage: 10 mg/kg Administration: i.p.; thrice-weekly for 10 weeks Result: Attenuated the development of kidney disease in diabetic mice. |
危险品标志 | Xi - 刺激性物品 |
风险术语 | 36/37/38 - 刺激眼睛、呼吸系统和皮肤。 |
安全术语 | 26 - 不慎与眼睛接触后,请立即用大量清水冲洗并征求医生意见。 |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.395 ml | 11.976 ml | 23.952 ml |
5 mM | 0.479 ml | 2.395 ml | 4.79 ml |
10 mM | 0.24 ml | 1.198 ml | 2.395 ml |
5 mM | 0.048 ml | 0.24 ml | 0.479 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!